Manning & Napier Group's ABT Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 171 shares of Abbott Laboratories (ABT) worth $21,508, representing 0.00% of the portfolio. First purchased in 2013-Q2, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Manning & Napier Group has maintained a strategic position in ABT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2022, adding 277,110 shares. Largest reduction occurred in Q2 2024, reducing 272,030 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Abbott Laboratories (ABT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Abbott Laboratories (ABT) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +16 | Add 10.32% | 171 | $125.78 |
| Q3 2025 | +155 | New Buy | 155 | $133.94 |
| Q2 2024 | -272,030 | Sold Out | 0 | $0.00 |
| Q1 2024 | -26,935 | Reduce 9.01% | 272,030 | $113.66 |
| Q4 2023 | -47,951 | Reduce 13.82% | 298,965 | $110.07 |
| Q3 2023 | -2,647 | Reduce 0.76% | 346,916 | $96.85 |
| Q2 2023 | +72,070 | Add 25.97% | 349,563 | $109.02 |
| Q1 2023 | -1,258 | Reduce 0.45% | 277,493 | $101.26 |
| Q4 2022 | +5,212 | Add 1.91% | 278,751 | $109.79 |
| Q3 2022 | -3,571 | Reduce 1.29% | 273,539 | $96.75 |
| Q2 2022 | +277,110 | New Buy | 277,110 | $108.65 |
| Q2 2017 | -194,870 | Sold Out | 0 | $0.00 |
| Q1 2017 | +40,598 | Add 26.32% | 194,870 | $44.40 |
| Q4 2016 | +4,909 | Add 3.29% | 154,272 | $38.41 |
| Q3 2016 | -2,858 | Reduce 1.88% | 149,363 | $42.29 |
| Q2 2016 | +152,221 | New Buy | 152,221 | $39.30 |
| Q4 2013 | -21,453 | Sold Out | 0 | $0.00 |
| Q3 2013 | -14,202 | Reduce 39.83% | 21,453 | $33.19 |
| Q2 2013 | +35,655 | Add 0.00% | 35,655 | $34.86 |
Manning & Napier Group's Abbott Laboratories Investment FAQs
Manning & Napier Group first purchased Abbott Laboratories (ABT) in Q2 2013, acquiring 35,655 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Abbott Laboratories (ABT) for 19 quarters since Q2 2013.
Manning & Napier Group's largest addition to Abbott Laboratories (ABT) was in Q2 2022, adding 277,110 shares worth $30.11 M.
According to the latest 13F filing for Q4 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 171 shares of Abbott Laboratories (ABT), valued at approximately $21,508.
As of the Q4 2025 filing, Abbott Laboratories (ABT) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Abbott Laboratories (ABT) was 349,563 shares, as reported at the end of Q2 2023.